Summary of opinion: Alhemo, 24/07/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 11:00
Summary of opinion: Alhemo, 24/07/2025 Positive
Summary of opinion: Taltz, 24/07/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 11:00
Summary of opinion: Taltz, 24/07/2025 Positive
New treatment for Niemann-Pick type C disease
Submitted by Anonymous (not verified) on 25 July 2025 - 11:00
New treatment for Niemann-Pick type C disease
Summary of opinion: Invokana, 24/07/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 11:00
Summary of opinion: Invokana, 24/07/2025 Positive
Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Submitted by Anonymous (not verified) on 25 July 2025 - 11:00
Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Orphan designation: Elesclomol-copper Treatment of Menkes disease, 22/06/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 10:52
Orphan designation: Elesclomol-copper Treatment of Menkes disease, 22/06/2025 Positive
Orphan designation: zanidatamab Treatment of biliary tract cancer, 27/06/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 10:45
Orphan designation: zanidatamab Treatment of biliary tract cancer, 27/06/2025 Positive
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 10:43
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 9:45
Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 9:37
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 16, Status: Authorised